Invasive Carcinoma — Trials

Invasive Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,812 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 603
Recruiting: 301
Ph III recruiting: 36
Growth YoY: +27.2%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

clinicaltrialsPublishedShowing 101–109 of 109 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00313612	Oxaliplatin and Topotecan in Advance Ovarian Cancer	terminated	Phase 2	39	National Cancer Institute (NCI)NIH	1	Nov 27, 2015	clinicaltrials
NCT00148720	Capecitabine in Women With Operable Breast Cancer	terminated	Phase 2	80	Dana-Farber Cancer InstituteOTHER	1	Nov 11, 2015	clinicaltrials
NCT01175772